SHOULDER INNOVATIONS, INC. Capital Expenditures
SHOULDER INNOVATIONS, INC. (SI) reported Capital Expenditures of $4.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $2.16M, a 46.93% increase year-over-year.
- SHOULDER INNOVATIONS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.73M, a 224.44% increase year-over-year.
- SHOULDER INNOVATIONS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $2.28M, a 118.79% increase year-over-year.
- SHOULDER INNOVATIONS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.81M, a 217.36% increase year-over-year.
- SHOULDER INNOVATIONS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $7.41M, a 84.51% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $4.01M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.89M 10-Q · filed 2026-08-06 | $7.17M derived: sum of 3 quarters · filed 2026-08-06 | $9.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.73M 10-Q · filed 2026-05-13 | $5.02M derived: sum of 2 quarters · filed 2026-05-13 | $7.83M derived: sum of 3 quarters · filed 2026-05-13 | $9.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $5.10M derived: sum of 2 quarters · filed 2026-03-10 | $6.57M derived: sum of 3 quarters · filed 2026-08-06 | $7.41M 10-K · filed 2026-03-10 |
| 2025-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.28M derived: sum of 2 quarters · filed 2026-08-06 | $5.13M 10-Q · filed 2025-11-12 | $6.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.31M 10-Q · filed 2026-08-06 | $3.35M derived: sum of 3 quarters · filed 2026-08-06 | $4.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $843.00K 10-Q · filed 2026-05-13 | $1.89M derived: sum of 2 quarters · filed 2026-05-13 | $2.77M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.93M derived: sum of 2 quarters · filed 2026-03-10 | $4.01M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $887.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.97M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $2.08M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |